Yang et al. subsequently used a direct labeling method for affibody ZHER2:V2 with 99mTc, demonstrating specific and efficient targeting of tumor imaging in HER2-overexpressing contexts [1]. The gene discussed is ERBB2; the disease is neoplasm.